Agendia is a healthcare startup specializing in molecular diagnostics and personalized medicine, particularly in the field of cancer diagnostics. The company operates in the healthcare market, serving clients such as hospitals, clinics, and other healthcare providers. Its business model revolves around the development and commercialization of innovative diagnostic tools and therapies, which are designed to improve patient outcomes and reduce healthcare costs.

The company's leadership team is composed of seasoned professionals with extensive experience in healthcare, diagnostics, and pharmaceuticals. This includes Kenyon Sweeney, who leads the commercial function, and Christy Garcia, who oversees compliance. The company's financial management and operations are led by Kurt, who has over fifteen years of experience in financial management and analytics in healthcare, banking, and aerospace industries. The company's research efforts are spearheaded by Prof. Laura van ‘t Veer, a recognized pioneer in the field of personalized medicine.

Agendia generates revenue through the sale of its diagnostic products and services to healthcare providers. The company's focus on personalized medicine, which involves tailoring medical treatment to individual patient characteristics, positions it well in a market that is increasingly recognizing the value of such approaches.

Keywords: Healthcare, Molecular Diagnostics, Personalized Medicine, Cancer Diagnostics, Commercialization, Compliance, Financial Management, Operations, Research, Revenue Generation.